Progress in Cardiovascular Diseases
Volume 46, Issue 1 , Pages 31-38 , July 2003

Environmental tobacco smoke and ischemic heart disease

  • Malcolm R Law

      Affiliations

    • Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Queen Mary’s School of Medicine and Dentistry, University of London, London, UK
    • ,
  • Nicholas J Wald

      Affiliations

    • Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Queen Mary’s School of Medicine and Dentistry, University of London, London, UK

References 

  1. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease (An evaluation of the evidence). BMJ. 1997;315:973–988
  2. He J, Vupputuri S, Allen K, et al.  Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiological studies. N Engl J Med. 1999;340:920–926
  3. Glantz SA, Parmley WW. Passive smoking and heart disease (Mechanisms and risk). JAMA. 1995;273:1047–1053
  4. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994;24:546–554
  5. Kritz H, Schmid P, Sinzinger H. Passive smoking and cardiovascular risk. Arch Intern Med. 1995;155:1942–1948
  6. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997;315:980–988
  7. Wald NJ, Boreham J, Bailey A, et al.  Urinary cotinine as marker of breathing other people’s tobacco smoke. Lancet. 1984;i:230–231
  8. Jarvis M, Tunstall-Pedoe H, Feyerabend C, et al.  Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984;38:335–339
  9. Scherer G, Conze C, Tricker AR, et al.  Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke. Clin Invest. 1992;70:352–367
  10. Celermajer DS, Adams MR, Clarkson P, et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–154
  11. Bailar JC. Passive smoking, coronary heart disease, and meta-analysis. N Engl J Med. 1999;12:958–959
  12. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour (Systematic review). BMJ. 2002;325:188–191
  13. Chapman S, Borland R, Brownson R, et al.  The impact of workplace smoking bans on declining cigarette consumption in Australia and the USA. Am J Public Health. 1999;89:1018–1023
  14. Hevey D, Slack K, Cahill A, et al.  Rates of smoking in the households of cardiac patients. J Cardiovasc Risk. 2002;9:271–274
  15. Law MR, Morris JK, Watt HC, et al.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer. 1997;75:1690–1693
  16. Layard MW. Ischemic heart disease and spousal smoking in the National Mortality Followback survey. Regul Toxicol Pharmacol. 1995;21:180–183
  17. LeVois ME, Layard MW. Publication bias in the environmental tobacco smoke/coronary heart disease epidemiological literature. Regul Toxicol Pharmacol. 1995;21:184–191
  18. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al.  Association between passive cigarette smoking and the risk of developing acute coronary syndromes (The CARDIO2000 Study). Heart Vessels. 2002;16:127–130
  19. Rosenlund M, Berglind N, Gustavsson A, et al.  Environmental tobacco smoke and myocardial infarction among never-smokers in the Stockholm Heart Epidemiology Program (SHEEP). Epidemiology. 2001;12:558–564
  20. McElduff P, Dobson AJ, Jackson R, et al.  Coronary events and exposure to environmental tobacco smoke (A case-control study from Australia and New Zealand). Tob Control. 1998;7:41–46
  21. Ciruzzi M, Pramparo P, Esteban O, et al.  Case-control study of passive smoking at home and risk of acute myocardial infarction. J Am Coll Cardiol. 1998;31:797–803
  22. Wells AJ. Heart disease from passive smoking in the workplace. J Am Coll Cardiol. 1998;31:1–9
  23. Howard G, Burke GL, Szklo M, et al.  Active and passive smoking are associated with increased carotid wall thickness. Arch Intern Med. 1994;154:1277–1282
  24. Steenland K, Thun M, Heath C. Environmental tobacco smoke and coronary heart disease. Circulation. 1997;96:2087–2088
  25. Law MR, Morris JK, Wald NJ. Passive smoking and heart disease (Authors’ reply to correspondence). BMJ. 1998;317:346
  26. Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. BMJ. 2003;326:1057–1061
  27. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations (An analysis of published data). BMJ. 1989;298:784–788
  28. Law MR, Wald NJ, Rudnicka AR. Statins (Quantifying the effect on LDL cholesterol and on ischaemic heart disease and stroke). BMJ. 2003;326:1423–1427
  29. Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease. Eur J Clin Nutr. 1997;52:549–556
  30. Elwood P, Renaud S, Sharp DS, et al.  Ischaemic heart disease and platelet aggregation (The Caerphilly collaborative heart disease study). Circulation. 1991;83:38–44
  31. Prentice RC, Carroll R, Scanlon PJ, et al.  Recent exposure to cigarette smoke increases myocardial infarct size. J Am Coll Cardiol. 1989;13:124A
  32. Zhu B, Sun Y, Sievers RE, et al.  Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994;89:1282–1290
  33. Zhu B, Sun Y, Sievers RE, et al.  L-arginine decreases infarct size in rats exposed to environmental tobacco smoke. Am Heart J. 1996;132:91–100
  34. Zhu BQ, Sievers RE, Browne AE, et al.  The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke. J Renin Angiotensin Aldosterone Syst. 2002;3:54–60
  35. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993;88:1820–1825
  36. Penn A, Chen L-C, Snyder CA. Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation. 1994;90:1363–1367
  37. Zhu B-Q, Sun Y-P, Sievers RE, et al.  Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993;21:225–232
  38. Sun Y-P, Zhu B-Q, Sievers RE, et al.  Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation. 1994;89:2260–2265

PII: S0033-0620(03)00078-1

doi: 10.1016/S0033-0620(03)00078-1

Progress in Cardiovascular Diseases
Volume 46, Issue 1 , Pages 31-38 , July 2003

Article Tools

* Image Usage & Resolution